Headlines

Nagpur: GMCH gets ICMR nod for conducting Plasma Therapy trials for treating COVID-19 patients


Amar Ashok Jajoo | May 7, 2020 20:30

GMCH in Nagpur has received ICMR nod for conducting clinical trials of convalescent plasma therapy to treat critically ill COVID-19 patients.
Government Medical College and Hospital in Nagpur

GMCH (Government Medical College and Hospital) in Nagpur has received ICMR (Indian Council of Medical Research) nod for conducting clinical trials of convalescent plasma therapy to treat critically ill COVID-19 patients. GMCH is among the 21 hospitals in the country to have received the approval.

Also read: Nagpur: 230 from Parvati Nagar quarantined after death of 22-year-old

Out of these 21 hospitals, five are from Maharashtra, four from Gujarat, two from Rajasthan, two from Madhya Pradesh, two from Tamil Nadu, two from Uttar Pradesh and one each from Punjab, Karnataka, Telangana and Haryana. Around 90 hospitals from across the country have also shown interest in conducting such trials and are under consideration.

Also read: We were abused for quarantine drive but it proved to be right strategy: NMC Commissioner Mundhe

Plasma therapy involves injecting the COVID-19 patient with the blood plasma of a recovered patient. People who get cured from COVID-19 develop anti-bodies, which drive the virus away. These anti-bodies from cured patient can be used to treat positive patients through convalescent plasma therapy.